Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Recruiting × spartalizumab × Clear all

Phase

Phase 2 27 Phase 1/2 8 Phase 1 7 Phase 3 4 Phase NA 3 Phase 2/3 3 Phase 4 1

Status

Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Propofol 8 Sevoflurane 6 Dexamethasone 6 Rituximab 5 Magnetic Resonance Spectroscopy 5 Specimen Handling 4 Nivolumab 4 Indocyanine Green 4 Capecitabine 4 Bupivacaine 4 Bevacizumab 4 pembrolizumab 3 Trastuzumab 3 Surgical Procedures, Operative 3 Standard of Care 3 Saline Solution 3 Metformin 3 Letrozole 3 Lenalidomide 3 Gemcitabine 3 Fluorouracil 3 Enoxaparin 3 Carboplatin 3 Acetaminophen 3 zanubrutinib 2 venetoclax 2 trastuzumab deruxtecan 2 trametinib 2 tislelizumab 2 semaglutide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06357598 2024-04-10

PILOT

The Affiliated Hospital of Qingdao University

Phase 4 Recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡